1448 results about "Peripheral oxygen saturation" patented technology

A signal processor generates basis functions and identifies at least one basis function component of a sensor signal in order to calculate a physiological measurement. The signal processor is advantageously applied to pulse oximetry so as to directly calculate oxygen saturation and so as to calculate a robust oxygen saturation measurement. In particular, a signal component transform may be calculated within a window around a derived pulse rate estimate. A signal component transform may also utilize sinusoidal basis functions, and an optimization of a signal component transform may occur at a particular frequency or a set of frequencies. A sinusoidal waveform or waveforms at that frequency or set of frequencies is generated to select associated red and infrared components of the sensor signal, and an oxygen saturation is calculated from a magnitude ratio of these components.

A pulse oximeter adaptively samples an input signal from a sensor in order to reduce power consumption in the absence of overriding conditions. Various sampling mechanisms may be used individually or in combination, including reducing the duty cycle of a drive current to a sensor emitter, intermittently powering-down a front-end interface to a sensor detector, or increasing the time shift between processed data blocks. Both internal parameters and output parameters may be monitored to trigger or override a reduced power consumption state. In this manner, a pulse oximeter can lower power consumption without sacrificing performance during, for example, high noise conditions or oxygen desaturations.

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

A wireless mobile device is provided for measuring pulse and blood oxygen saturation (SpO2). The device may include a SpO2 sensor, a pulse sensor, and a main controller to receive and process signals from the SpO2 and the Pulse sensors, and to enable reconfiguration of the SpO2 and the Pulse sensors by commands received from a remote server. The device may include a light measurement module to measure pulse parameters, and a light measurement module to measure SpO2 parameters, the light measurement modules including an emitting/receiving unit and an electronic unit.

The present invention relates to novel nasal pulse oximeter probes that are configured to be placed across the septum of the nose. These probes are fabricated to provide signals to obtain arterial oxygen saturation and other photoplethysmographic data. The present invention also relates to a combined nasal pulse oximeter probe/nasal cannula. The present invention also relates to other devices that combine a pulse oximeter probe with a device supplying oxygen or other oxygen-containing gas to a person in need thereof, and to sampling means for exhaled carbon dioxide in combination with the novel nasal probe. In certain embodiments, an additional limitation of a control means to adjust the flow rate of such gas is provided, where such control is directed by the blood oxygen saturation data obtained from the pulse oximeter probe.

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.

A home-based remote care solution provides sensors including a basic health monitor (BHM) that is a measurement and feedback system. The BHM operates with low power integrated communications combined with an in-home, low power mesh network or programmable digital assistant (PDA) with cell phone technology. A cognitive system allows remote monitoring of the location and the basic health of an individual. The BHM measures oxygen saturation (SaO2), temperature of the ear canal, and motion, including detection of a fall and location within a facility. Optionally, the BHM measures CO2, respiration, EKG, EEG, and blood glucose. No intervention is required to determine the status of the individual and to convey this information to care providers. The cognitive system provides feedback and assistance to the individual while learning standard behavior patterns. An integrated audio speaker and microphone enable the BHM to deliver audio alerts, current measurements, and voice prompts. A remote care provider can deliver reminders via the BHM. The device may be worn overnight to allow monitoring and intervention. Through the ability to inquire, the cognitive system is able to qualify events such as loss of unconsciousness or falls. Simple voice commands activate the device to report its measurements and to give alerts to care providers. Alerts from care providers can be in a familiar voice to assist with compliance to medication regimens and disease management instructions. Simple switches allow volume control and manual activation. The device communicates with a series of low-power gateways to an in-home cognitive server and point-of-care (POC) appliance (computer). Alone the BHM provides basic feedback and monitoring with limited cognitive capabilities such as low oxygen or fall detection. While connected to the cognitive server, full cognitive capabilities are attained. Full alerting capability requires the cognitive server to be connected through an Internet gateway to the remote care provider.

A combination of a patient core temperature sensor and the dual-wavelength optical sensors in an ear probe or a body surface probe improves performance and allows for accurate computation of various vital signs from the photo-plethysmographic signal, such as arterial blood oxygenation (pulse oximetry), blood pressure, and others. A core body temperature is measured by two sensors, where the first contact sensor positioned on a resilient ear plug and the second sensor is on the external portion of the probe. The ear plug changes it's geometry after being inserted into an ear canal and compress both the first temperature sensor and the optical assembly against ear canal walls. The second temperature sensor provides a reference signal to a heater that is warmed up close to the body core temperature. The heater is connected to a common heat equalizer for the temperature sensor and the pulse oximeter. Temperature of the heat equalizer enhances the tissue perfusion to improve the optical sensors response. A pilot light is conducted to the ear canal via a contact illuminator, while a light transparent ear plug conducts the reflected lights back to the light detector.

A diagnosis method and apparatus for measuring blood hemoglobin concentration, oxygen saturation, pulse rate, respiration rate, or degree of aging of blood vessels using light includes an input/output unit for receiving a command for measurement from a user and for providing information on the result of a measurement to the user; a control unit for receiving the command for measurement from the input/output unit and for generating a control signal; a light generating unit for generating at least two light beams for measurement according to the control signal; a light receiving unit for receiving the light beams transmitted through an object that is subject to measurement and for converting the received light beams into electrical signals; and a data processing unit for processing the electrical signals received from the light receiving unit and for outputting information on the result of a predetermined measurement.

An electronic endoscope system includes a light source device for sequentially emitting light having different wavelength bands, an electronic endoscope for receiving reflected light of light sequentially illuminating a subject tissue containing a blood vessel in a body cavity and sequentially outputting an imaging signal corresponding to the wavelength band of the received light, an aligner for aligning images corresponding to imaging signals obtained using light having different wavelength bands outputted from the electronic endoscope, an image producer for producing an oxygen saturation level image representing the distribution of the oxygen saturation level in the blood vessel in a given depth from the imaging signals of the images aligned by the aligner, and an image display for displaying the oxygen saturation level image produced by the image producer.

Non-invasive, optical apparatus and methods for the direct measurement of hemoglobin derivatives and other analyte concentration levels in blood using diffuse reflection and transmission spectroscopy in the wavelength region 400-1350 nm which includes the transparent tissue window from approximately 610 to 1311 nanometers and, using diffuse reflection spectroscopy, the mid-infrared region from 4.3-12 microns in wavelength. Large area light collection techniques are utilized to provide a much larger pulsate signal than can be obtain with current sensor technology. Sensors used in separate or simultaneous precision measurements of both diffuse reflection and transmission, either separately or simultaneously, from pulsate, blood-perfused tissue for the subsequent determination of the blood analytes concentrations such as arterial blood oxygen saturation (SaO₂), carboxyhemoglobin (COHb), oxyhemoglobin (OHb), deoxyhemoglobin (dOHb), methemoglobin (metHb), water (H2O), hematocrit (HCT), glucose, cholesterol and proteins such as albumin and other analytes components.

Blood sugar levels are measured non-invasively based on temperature measurement. Non-invasively measured blood sugar level values obtained by a temperature measurement scheme are corrected by blood oxygen saturation and blood flow volume, thereby stabilizing the measurement data.

An embodiment of the present invention comprises a self-contained breathing apparatus (SCBA) mask that incorporates a series of physiologic sensors. These physiologic sensors are mounted on the interior of the SCBA mask in such a way as to contact the facial skin of an individual wearing the mask. The physiologic sensors monitor, among other things, heart rate and carbon monoxide and oxygen saturation levels. The physiologic sensors are connected to a transmitting apparatus attached to the SCBA. The SCBA transmitter sends output data from the physiologic sensors to a remote processor. The SCBA transmitter also sends location information of the individual wearing the SCBA mask to the remote processor. The remote processor compiles the physiologic and location data for the wearer of the SCBA and transmits a signal back to the SCBA receiver which, in turn, sends a signal to a display integrated into a SCBA mask. The display indicates to the individual his physiologic status. The display incorporates indicator lights are integrated into the mask of the SCBA to indicate, for example, when bottled air must be switched on, to indicate the emergency situation of the wearer and/or to indicate the direction that the wearer of the SCBA is going. The processor associated with the transmitter also monitors groups of individuals wearing the SCBA masks. In this way, the particular status of several individuals in hazardous environment can be monitored at once and their situation known over a period of time in the hazardous conditions. Specifically, the physiologic condition of the group can be monitored to track the changes in the group condition over the time that the group is exposed to the hazardous environment.

A method and apparatus for non-invasively determining the blood oxygen saturation level within a subject's tissue is provided that utilizes a near infrared spectrophotometric (NIRS) sensor capable of transmitting a light signal into the tissue of a subject and sensing the light signal once it has passed through the transmitting a light signal into the subject's tissue, wherein the transmitted light signal includes a first wavelength, a second wavelength, and a third wavelength; (2) sensing a first intensity and a second intensity of the light signal, along the first, second, and third wavelengths after the light signal travels through the subject at a first and second predetermined distance; (3) determining an attenuation of the light signal for each of the first, second, and third wavelengths using the sensed first intensity and sensed second intensity of the first, second, and third wavelengths; (4) determining a difference in attenuation of the light signal between the first wavelength and the second wavelength, and between the first wavelength and the third wavelength; and (5) determining the blood oxygen saturation level within the subject's tissue using the difference in attenuation between the first wavelength and the second wavelength, and the difference in attenuation between the first wavelength and the third wavelength.

A fetal blood pulse oximetry method and apparatus using a first wavelength of light at about 655 to 705 nm and a second wavelength of light at about 820 to 900 nm. Measurements are taken through a mother's abdomen. Processing is performed to extract absorption information related to fetal arterial blood with calculation of fetal oxygen saturation from the extracted data.